The overall mortality rate for U.S. patients with cardiovascular disease has improved significantly in recent years. At the ...

Enoumena Therapeutics Inc. and AOP Health today announced an exclusive commercialization agreement to expand Canadian ...

Despite sustained declines in overall cardiovascular disease mortality in the U.S., disparities based on race, ethnicity and ...

Cardiovascular disease (CVD) mortality rates in the United States substantially decreased between 2000 and 2019, but the pace ...

Despite sustained declines in overall cardiovascular disease mortality in the U.S., disparities based on race, ethnicity and ...

Eli Lilly's noncovalent BTK inhibitor Jaypirca has been cleared by the FDA in its first frontline indication for chronic ...

Jaypirca, the first-and-only FDA-approved non-covalent BTK inhibitor, is a highly selective kinase inhibitor that utilizes a ...

Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved an additional indication for Jaypirca (pirtobrutinib, 100 mg & 50 mg tablets), a non-covalent ...

Although AFib doesn’t always cause noticeable symptoms, knowing the signs can help you protect your health. AFib can feel ...

A doctor explains that not all irregular heartbeats are dangerous, and an 84-year-old cyclist's active lifestyle suggests his ...

You recently used the term “abnormal irregular heartbeat.” I’ve had an irregular heartbeat for decades without seemingly ill ...

A perfectly regular heartbeat is actually a sign of poor heart health, according to a cardiologist's explanation of normal ...